25th Aug 2015 14:49
TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
Spire Healthcare Group plc
2. Reason for the notification (please state Yes/No):
An acquisition or disposal of voting rights: YES
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached:
An event changing the breakdown of voting rights: ( )
Other (please specify):
3. Full name of person(s) subject to the notification obligation:
remgro limited
4. Full name of shareholder(s) (if different from 3.):
REMGRO JERSEY LIMITED
5. Date of the transaction (and date on which the threshold is crossed or reached if different): 24 August 2015
6. Date on which issuer notified: 25 August 2015
7. Threshold(s) that is/are crossed or reached:
Prior to transaction: 29.9% Subsequent to transaction below 3%
8. Notified details: | |||||||
A: Voting rights attached to shares viii, ix | |||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | |||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | |||
Direct | Direct xi | Indirect xii | Direct | Indirect | |||
ORDINARY ISIN: GB00BNLPYF73 | 119,923,335 | 119,923,335 | 0 | 0
| |||
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument | Expiration Date | Exercise/Conversion Period/ Date | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights |
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument | Exercise price | Expiration date | Exercise/Conversion period | Number of voting rights instrument refers to | % of voting rights |
Nominal | Delta | ||||
Total (A+B+C)
| |
Number of voting rights | % of voting rights |
0 | 0% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
1. REMGRO LIMITED (ULTIMATE PARENT): INDIRECT HOLDING OF 29.9% OF VOTING RIGHTS IN ISSUER
2. REMGRO HEALTHCARE HOLDINGS (PTY) LTD [CURRENTLY KNOWN AS FRIEDSHELF 1670, IN PROCESS OF BEING RENAMED] (WHOLLY OWNED SUBSIDIARY OF REMGRO LIMITED): INDIRECT HOLDING OF 29.9% OF VOTING RIGHTS IN ISSUER
3. BUSINESS VENTURE INVESTMENTS NO 1871 (PTY) LTD (WHOLLY OWNED SUBSIDIARY OF REMGRO HEALTHCARE HOLDINGS (PTY) LTD): INDIRECT HOLDING OF 29.9% OF VOTING RIGHTS IN ISSUER
4. REMGRO JERSEY LIMITED (WHOLLY OWNED SUBSIDIARY OF BUSINESS VENTURE INVESTMENTS NO 1871 (PTY) LTD): DIRECT HOLDING OF 29.9% OF VOTING RIGHTS IN ISSUER
Please note that it is only the interests of parties 1 and 2 which have changed. The interests of parties 3 and 4 remain unchanged.
Proxy Voting:
10. Name of the proxy holder: N/A
11. Number of voting rights proxy holder will cease to hold: N/A
12. Date on which proxy holder will cease to hold voting rights: N/A
13. Additional information:
14. Contact name:
Anthony Dand, Interim Deputy Secretary, Spire Healthcare Group plc
15. Contact telephone number:
+ 44 (0)20 7427 9092
Related Shares:
Spire Healthcare